FIGURE 1. Changes in serum creatinine concentration and creatinine clearance with time after ®rst admission. D=discharged; A=re-admitted; =assumed incomplete urine collection (urine creatinine 6 mmol/volume).
CASE REPORT
A 21-year-old woman was ®rst referred to a rheumatologist (HAC) when aged 14 years. She had developed progressive joint discomfort and was diagnosed as having juvenile chronic arthritis (rheumatoid-factor-negative polyarticular arthritis). 1 She had previously required several steroid injections and had been on sulphasalazine, hydroxychloroquine, gold and methotrexate; on this admission she remained on hydroxychloroquine. Two weeks before this admission, she had been given steroid injections into her metacarpophalangeal and proximal interphalangeal joints but continued to complain of increasing pain and stiffness in her hands, wrists and knees. Her left wrist and left knee were aspirated and there was no growth on culture. She was therefore admitted (day 0) and received steroid injections into both knees with a good symptomatic response. Shortly after admission, she developed a vasculitic rash on her legs which spread to her buttocks and forearms.
On day 1, her C-reactive protein (CRP) was 115 mg/L (reference range 10) and the erythrocyte sedimentation rate was 71 mm/h (reference range 12). Investigations showed that she was negative for anti-nuclear antibody (ANA) and rheumatoid factor (RF), with normal complement C3 and reduced complement C4. Serum cryoglobulins were negative. Serum immunoglobulin IgG was 15´8 g/L (reference range 6±15); IgA and IgM concentrations were within reference ranges. Albumin excretion was 1´9 mg/mmol creatinine.
Her rash began to fade and her CRP fell to 15 mg/L on day 5 without intervention; she was therefore discharged on day 6. However, shortly after discharge, the rash intensi®ed and was consistent with Henoch±SchoÈ nlein purpura. When she was seen as an out-patient on day 10, her CRP was 48 mg/L. ANA, RF and C3 remained normal and C4 was reduced; these did not change throughout this study. On days 12 and 14, screens for pANCA (perinuclear antibodies to neutrophil cytoplasmic antibodies) were weakly positive at 1/40. A con®rmatory test on formalin-®xed neutrophils was inconclusive, but ethanol-®xed neutrophils identi®ed pANCA. Screens for cytoplasmic antibodies to neutrophil cytoplasmic antibodies (cANCA) were negative. No further requests were made for pANCA or cANCA.
She was re-admitted on day 13. On examination, her skin was seen to have broken down over the dorsum of her feet and she had developed a vasculitic ulcer on her left foot. This became infected and swabs grew a Proteus species. CRP rose to 83 mg/L on day 17. She was treated with appropriate dressings and intravenous antibiotics (amoxycillin and clavulanic acid on days 15±19, and amoxycillin and gentamicin on days 26±33). Oral¯ucloxacillin was given from day 33 to day 39. A skin biopsy demonstrated a leucocytoclastic vasculitis. She was started on steroids (methylprednisolone, 40 mg on alternate days) and an immunosuppressant (azathioprine, 50 mg/day, which was increased to 75 mg/day from day 27 and to 100 mg/day from day 34). CRP fell on therapy, but¯uctuated and remained elevated.
Creatinine clearance was requested because of the potential toxic effects of drug therapy and because Henoch±SchoÈ nlein purpura, which is associated with glomerulonephritis, was suspected. Serial results for serum creatinine concentration and creatinine clearance are shown in Fig. 1 . Her serum creatinine remained stable, apart from a rise within the reference range on days 16 and 17. Creatinine clearance may also have been stable but interpretation is
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Ann Clin Biochem 2000; 37: 224±227 confounded by the problem of incomplete urine collections. She developed marked proteinuria ( Fig. 2 ), which persisted for at least 6 weeks. She was reviewed by renal physicians and a renal biopsy was performed on day 21 after her ®rst admission. This showed mild to moderate mesangial proliferative glomerulonephritis, and electron microscopy suggested immune complexes in the mesangium and the subendothelial space. Immuno¯uorescence was positive for IgA and C3 and the diagnosis of Henoch±SchoÈ nlein purpura was con®rmed. Her serum IgA concentration on days 1, 2 and 14 remained within the reference range. During this admission, she had some episodes of generalized abdominal discomfort. Abdominal ultrasound was unremarkable and her pain may have been related to the Henoch±SchoÈ nlein purpura. It had settled by the time she was discharged.
Her serum liver function tests and urea and electrolyte concentrations remained within reference ranges. However, her serum albumin decreased (the lowest concentration, 24 g/L, was on day 37) and she developed some peripheral oedema, which was treated with frusemide. Her albumin excretion (Fig. 2 ) remained high on day 41 when she was discharged. Her CRP was then 45 mg/L. It did not fall below 10 mg/L until day 75.
Her haemoglobin on admission was 10´3 g/dL (reference range 11´5±16´5), with mean corpuscular volume, red cell folate, serum vitamin B 12 and ferritin all within reference ranges. Her serum folate was 3´2 g/L (reference range 3´5± 16´0). She remained on ferrous sulphate and her haemoglobin on discharge was 10´0 g/L.
She was discharged on hydroxychloroquine 400/200 mg on alternate days, prednisolone 40 mg on alternate days, ranitidine 150 mg b.d., co-proxamol two tablets p.r.n., ephedrine nasal drops q.i.d., ibuprofen retard 800 mg b.d., prochlorperazine 5 mg t.i.d., chlorpheniramine 4 mg p.r.n., ferrous sulphate 200 mg o.d., lactulose 10 ml b.d., azathioprine 100 mg o.d. and frusemide 40 mg o.d.
The plan for her management after discharge included weekly 24-h urine collections for protein and creatinine estimation, and for her current dose of steroids to be continued until proteinuria decreased (Fig. 2) . Urine samples were then to be collected monthly. However, this was confounded by problems with inaccurate urine collections. Our reference range for urine creatinine is 8±18 mmol/24 h, and if the urine creatinine is found to be less than 6 mmol/ volume it is assumed to be incomplete. On the basis of this criterion, four out of the 11 collections were incomplete. Urine on day 35 with a creatinine of 6´0 mmol/volume was also probably incomplete. The urine albumin:creatinine ratio, which is more reliable than the 24-h albumin excretion, did decline with time, but was still elevated 4 months after this admission (Fig. 2) . Despite her mobility problems, she has remained active and employed.
DISCUSSION
Juvenile chronic arthritis 1 is a clinically heterogeneous group of idiopathic arthritides occurring in children younger than 16 years; the polyarticular, RF-negative subgroup is usually diagnosed in the teenage years, as in this case. 1 Prognosis is poor and treatment is the same as for adult rheumatoid arthritis.
Renal dysfunction is common in the chronic arthritides, 2 but her creatinine and albumin excretion had remained normal until the present episode. Henoch±Scho È nlein purpura is the association of arthritis, palpable purpura, gut symptoms and IgA nephropathy. 3 It is con-®rmed, as in this case, by positive immuno¯uorescence for IgA and C3 within the vasculitic skin lesions and glomerular mesangia. Only about half of patients have an elevated serum IgA. A genetic susceptibility is likely and the disorder may often be precipitated by an upper respiratory or gastrointestinal infection. 3, 4 Henoch± SchoÈ nlein purpura occurs more commonly in children than adults. 4 A higher prevalence might therefore be expected in juvenile chronic arthritis than in adult-onset rheumatoid arthritis. However, it is not cited in a recent review 1 of juvenile chronic arthritis. Assessment of renal function is essential in the use of the immunosuppressant azathioprine. 5 The serum creatinine concentration has a high degree of individuality and the usefulness of conventional population-based reference ranges is limited. 6 Her serum creatinine increased brie¯y by about 30% around day 17, but this was not related to the timing of the increase in her dose of azathioprine.
About half of the attempts to estimate creatinine clearance in this patient were unsuccessful. Although she was a cooperative subject she had problems in collecting urine, partly because of her impaired mobility. Her creatinine clearance probably remained stable for most of the period of study, apart from a few days after her re-admission to hospital. Even when urine is collected by highly committed volunteers, it has been shown that to be con®dent of any change in renal function, two creatinine clearance measurements must differ by 35±45%. In contrast, a change of 14±15% in serum creatinine will be signi®cant. 6 Changes in serum creatinine therefore better re¯ect true changes in function in any individual. Serum cystatin concentration 7 is potentially a better marker for detecting impaired renal function than serum creatinine is, but serum creatinine is probably still the better marker for detecting temporal changes in any individual subject.
This patient developed the nephrotic syndrome. 8 Urine albumin was used as a marker of the response to therapy, particularly of azathioprine. Albumin is preferable to total protein for the assessment of glomerular proteinuria 9 because it is a homogeneous protein and superior assays are available. Almost all albumin ®ltered by the glomerulus is normally re-absorbed by mechanisms that are close to saturation. A small increase in glomerular vascular permeability will lead to more albumin being presented to the renal tubules. This excess protein cannot be re-absorbed and a large increase in albumin excretion results. In patients with nephropathy, higher rates of protein excretion are associated with more rapid progression of renal disease. 10 Therapy to decrease protein excretion will slow the rate of decline in glomerular ®ltration rate. In the chronic proteinuric nephropathies, the ratio of protein to creatinine in a single morning urine was found to correlate with 24-h urine protein and was better than the measurement of 24-h urine protein in predicting the rate of decline in glomerular ®ltration rate and progression to end-stage renal disease. 10 Screening for proteinuria is a common requirement in rheumatological practice, particularly in patients who are receiving second-line drugs. 11 The use of the urine protein:creatinine ratio rather than the 24-h excretion was also of practical value in monitoring the effects of drug therapy in this group of patients. Collection of a random, rather than a 24-h, urine is more convenient and avoids errors due to incomplete urine collection. It is of marked bene®t to patients with rheumatoid arthritis who have impaired mobility.
